Up-Regulation of Vascular Endothelial Growth Factor in Stromal Cells of Hemangioblastomas Is Correlated with Up-Regulation of the Transcription Factor HRF/HIF-2α-Reference-Cited by-同舟云学术

Up-Regulation of Vascular Endothelial Growth Factor in Stromal Cells of Hemangioblastomas Is Correlated with Up-Regulation of the Transcription Factor HRF/HIF-2α

Published:1998-07 Issue:1 Volume:153 Page:25-29
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Flamme Ingo,Krieg Marion,Plate Karl H.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference28 articles.

1. Pathology, genetics and cell biology of hemangioblastomas;Wizigmann-Voos;Histol Histopathol,1996

2. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas;Wizigmann-Voos;Cancer Res,1995

3. Molecular and biological properties of the vascular endothelial growth factor family of proteins;Ferrara;Endocr Rev,1992

4. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis;Millauer;Cell,1993

5. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth;Peters;Proc Natl Acad Sci USA,1993

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Versatile roles of Annexin A4 in ccRCC: impact on membrane repair, transcriptional signatures, and composition of the tumor microenvironment;2024-06-03

2. Oral Hypoxia-Inducible Factor 2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease;Ophthalmology;2024-06

3. Benign Spinal Tumors;Advances in Experimental Medicine and Biology;2023

4. A Review on the Design, Synthesis, and Structure-activity Relationships of Benzothiazole Derivatives against Hypoxic Tumors;Current Organic Synthesis;2022-11

5. Neurological applications of belzutifan in von Hippel-Lindau disease;Neuro-Oncology;2022-10-10